Pharmaceutical Drug Delivery Market

The pharmaceutical drug delivery market accounted for $1,200 billion in 2018, and is expected to reach $1,733 billion by 2026, registering a CAGR of 4.7% from 2019 to 2026. 

A pharmaceutical drug delivery (DDS) is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. This system functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. DDS is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body. Moreover, various routes of administration are used to introduce drug delivery system into the body, which include oral drug delivery, pulmonary drug delivery, injectable drug delivery, nasal drug delivery, and others.  

The major factor that contributes to the growth of pharmaceutical drug delivery market include surge in awareness related to use of pharmaceutical drug delivery systems. Furthermore, other factors such as rise in healthcare expenditure and surge in governmental support for research in the field of drug delivery fuel the growth of pharmaceutical drug delivery market. In addition, increase in prevalence of various chronic diseases, which require the use of pharmaceutical drug delivery systems is another major factor that contributes to the growth of market. However, rise in number of drug recalls and drug failures restricts the growth of pharmaceutical drug delivery market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period. 

Pharmaceutical Drug Delivery Market Segmentation  

The pharmaceutical drug delivery market size is studied on the basis of route of administration, application, and region to provide a detailed assessment of the market. On the basis of route of administration, it is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, nasal drug delivery, ocular drug delivery, topical drug delivery, and others. By application, it is fragmented into cancer, diabetes, respiratory diseases, cardiovascular diseases, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA). 
 
Segment Review

According to route of administration, the others segment occupied the largest share of pharmaceutical drug delivery market in 2018, and is expected to grow at the fastest pace during the forecast period, owing to rise in awareness related to the use of drug delivery systems and increase in the healthcare expenditure.

By application, the cancer segment occupied the largest share of the pharmaceutical drug delivery market. This growth is attributable to surge in prevalence of cancer. Moreover, rise in need for novel and advanced therapeutics required for cancer treatment is another factor that boots the growth of the market. Furthermore, others segment is expected to grow at the fastest pace during the forecast period, owing to rise in prevalence of various disorders such as respiratory disorders such as asthma and bronchitis. 

Region wise, North America accounted for the major pharmaceutical drug delivery market share in 2018, and is expected to continue this trend, owing to easy availability of pharmaceutical drug delivery systems. Moreover, surge in prevalence of various chronic conditions such as cancer, respiratory diseases, and cardiovascular diseases is another major reason that contributes to the growth of this market. However, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to increase in awareness regarding the use of pharmaceutical drug delivery products. The constantly evolving life science industry drives the growth of the market in developing economies such as India, China, and Malaysia, as constant developments lead to surge in awareness related to the use of pharmaceutical drug delivery.

The global pharmaceutical drug delivery market is highly competitive, owing to presence of prominent players in the market. These players have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market are Bayer AG, Becton, Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, 3M Company, Pfizer Inc., and Sanofi.

Key Benefits for Stakeholders:

• This report entails a detailed quantitative analysis along with the current global pharmaceutical drug delivery market trends from 2018 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The pharmaceutical drug delivery market forecast is studied from 2019 to 2026. 
• The market size and estimations are based on a comprehensive analysis of key developments in the industry. 
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

 Pharmaceutical Drug Delivery Market Report Highlights